サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553527

移植診断の世界市場規模、シェア、動向分析：検査別、製品別、用途別、移植部位別、最終用途別、地域別、セグメント別予測（2024年～2030年）

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
移植診断の世界市場規模、シェア、動向分析：検査別、製品別、用途別、移植部位別、最終用途別、地域別、セグメント別予測（2024年～2030年）
出版日: 2024年08月20日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

移植診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の移植診断の市場規模は、2024年～2030年にCAGR7.3％を記録し、2030年には97億4,000万米ドルに達すると予測されています。

臓器不全を頻繁に引き起こす慢性疾患を患う患者の増加により、移植手術の需要が急増しています。さらに、幹細胞治療や個別化医療の採用が拡大しており、移植診断の需要に影響を与えています。

臓器移植に伴うリスクと複雑性から、改良された高度な診断ツールが必要とされています。次世代シーケンシング（NGS）技術は、精度を高めた高スループットの診断ツールに対する需要の高まりにより、ヒト白血球抗原（HLA）タイピングに採用されている血清学的手法などの従来の診断手法に急速に取って代わりつつあります。

市場の成長は、世界の一部の地域における償還論争や倫理的問題などの要因によって抑制されると予想されます。さらに、ポリメラーゼ連鎖反応（PCR）やNGS装置を用いたHLAマッチングを実施するためのコストが高いことが、新興諸国における移植診断市場の成長に影響を与えています。

移植診断市場レポートハイライト

  • シーケンスベースのタイピングセグメントは、2024年～2030年に大きな成長が見込まれます。NGSの高い採用率がセグメント成長の主な要因です。
  • 北米は2023年に最大の収益シェアを獲得し、確立された研究インフラ、ヘルスケア支出の増加、高度な診断技術の高い採用、研究開発活動の活発化により、予測期間を通じて優位性を維持すると予測されます。
  • アジア太平洋は、研究機会の拡大、医療支出、医療ツーリズム産業、臓器提供に関する意識により、予測期間中に大きな成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 移植診断市場の変数、動向、範囲

  • 市場のイントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 移植診断市場の分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 移植診断市場：検査の推定・動向分析

  • セグメントダッシュボード
  • 移植診断市場：検査の分析（2023年・2030年）
  • 分子アッセイ
  • シークエンシングベースの分子アッセイ
  • 非分子アッセイ

第5章 移植診断市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 移植診断市場：製品の分析（2023年・2030年）
  • 試薬・消耗品
  • 機器
  • ソフトウェアとサービス

第6章 移植診断市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 移植診断市場：用途の分析（2023年・2030年）
  • 診断用途
    • 感染症検査
    • 組織適合性検査
    • 血液プロファイリング
  • 研究用途

第7章 移植診断市場：移植部位の推定・動向分析

  • セグメントダッシュボード
  • 移植診断市場：移植部位の分析（2023年・2030年）
  • 固形臓器移植
  • 幹細胞移植
  • 軟部組織移植
  • 骨髄移植

第8章 移植診断市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 移植診断市場：最終用途の分析（2023年・2030年）
  • 病院・移植センター
  • 研究・学術機関
  • 独立リファレンスラボ

第9章 移植診断市場：地域の推定・動向分析

  • 移植診断市場シェア：地域別（2023年・2030年）
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • F. Hoffmann La-Roche Ltd
    • Abbott
    • QIAGEN
    • Bruker
    • BD（Becton, Dickinson and Company）
    • Werfen（Immucor, Inc.）
    • Bio-Rad Laboratories, Inc.
    • Omixon Inc.
目次
Product Code: 978-1-68038-970-8

Transplant Diagnostics Market Growth & Trends:

The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Transplant Diagnostics Market Report Highlights:

  • The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
  • North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
  • Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transplant Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transplant Diagnostics: Test Outlook Analysis, USD Million, 2023 & 2030
  • 4.3. Molecular Assays
    • 4.3.1. PCR-based Molecular Assays
      • 4.3.1.1. PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Real-Time PCR
      • 4.3.2.1. Real-Time PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Sequence-based Primer-PCR
      • 4.3.3.1. Sequence-based Primer-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Sequence-specific Oligonucleotide-PCR
      • 4.3.4.1. Sequence-specific Oligonucleotide-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Other PCR-based Molecular Assays
      • 4.3.5.1. Other PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Sequencing-based Molecular Assays
    • 4.4.1. Sanger Sequencing
      • 4.4.1.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Next Generation Sequencing
      • 4.4.2.1. Next Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Other Sequencing-based Molecular Assays
      • 4.4.3.1. Other Sequencing-based Molecular Assays Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Non-molecular Assays
    • 4.5.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.1. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transplant Diagnostics Market: Product Analysis, USD Million, 2023 & 2030
  • 5.3. Reagents & Consumables
    • 5.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Software and Services
    • 5.5.1. Software and Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transplant Diagnostics Market: Application Analysis, USD Million, 2023 & 2030
  • 6.3. Diagnostics Application
    • 6.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Infectious Disease Testing
      • 6.3.2.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Histocompatibility Testing
      • 6.3.3.1. Histocompatibility Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Blood Profiling
      • 6.3.4.1. Blood Profiling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Application
    • 6.4.1. Research Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transplant Diagnostics Market: Transplant Area Analysis, USD Million, 2023 & 2030
  • 7.3. Solid Organ Transplantation
    • 7.3.1. Kidney Transplantation
      • 7.3.1.1. Kidney Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Liver Transplantation
      • 7.3.2.1. Liver Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Heart Transplantation
      • 7.3.3.1. Heart Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Lungs Transplantation
      • 7.3.4.1. Lungs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Pancreas Transplantation
      • 7.3.5.1. Pancreas Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Other Organs Transplantation
      • 7.3.6.1. Other Organs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Stem Cell Transplantation
    • 7.4.1. Stem Cell Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Soft Tissue Transplantation
    • 7.5.1. Soft Tissue Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Bone Marrow Transplantation
    • 7.6.1. Bone Marrow Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Transplant Diagnostics Market: End Use Analysis, USD Million, 2023 & 2030
  • 8.3. Hospitals and Transplant Centers
    • 8.3.1. Hospitals and Transplant Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Research and Academic Institutes
    • 8.4.1. Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Independent Reference Laboratories
    • 8.5.1. Independent Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Transplant Diagnostics Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.K.
      • 9.3.2.1. U.K. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. China Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Australia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. South Korea Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Saudi Arabia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. UAE Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Illumina, Inc.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. F. Hoffmann La-Roche Ltd
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. Abbott
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. QIAGEN
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Bruker
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. BD (Becton, Dickinson and Company)
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. Werfen (Immucor, Inc.)
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives
    • 10.4.9. Bio-Rad Laboratories, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Recent Developments/ Strategic Initiatives
    • 10.4.10. Omixon Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Recent Developments/ Strategic Initiatives